The trajectory of companies tied to the drug's history presents a challenging investment picture . While the initial boom generated substantial returns , generic competition have significantly diminished https://bookmarkeasier.com/story21475655/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-opportunity